Atlas Trials

Mature B-cell Malignancies

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Mature B-cell Malignancies

RecordFirmDate
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies (NCT06351527)InnoCare Pharma Inc.2024-04-23
Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies (NCT04883957)BeiGene2021-07-05
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies (NCT04277637)BeOne Medicines2020-03-24
Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies (NCT04172246)BeiGene2020-01-29

Track Mature B-cell Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.